Drug · DIN 02100487
VERELAN
No: no longer authorized
The company stopped selling it and its DIN was cancelled. A cancellation is most often a business decision; the record does not say why.
Status Cancelled Post Market since November 24, 2025; first marketed December 31, 1994.
- Drug Identification Number (DIN)
- 02100487
- Company (DIN owner)
- Recro Gainesville LlcGainesville, Georgia, United States
- Schedule
- Prescription
- Dosage form
- Capsule (Sustained-Release)
- Route
- Oral
- Therapeutic class (ATC)
- Verapamil C08DA01
- Class
- Human
- Record last updated
- June 24, 2026
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| VERAPAMIL HYDROCHLORIDE | 180 MG |
Notices of Compliance
Health Canada approvals that name this DIN.
- June 3, 2015: NOC 16963New Drug Submission (NDS) · Merger - buyout
- January 19, 2012: NOC 12942New Drug Submission (NDS) · Manufacturer name change
- June 20, 1994: NOC 5632New Drug Submission (NDS)
Other DINs named VERELAN
- DIN 02100479 · Cancelled Post Market
- DIN 02100495 · Cancelled Post Market